These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Immediate- and late-hemodynamic coronary effects of tadalafil in men with erectile dysfunction and coronary artery disease. Bellotto F, Ruscazio M, Bonanni G, Montisci R, Cutolo A, Sarais C, Setzu T, Borrini A, Iliceto S. Int J Impot Res; 2008; 20(2):168-72. PubMed ID: 17703220 [Abstract] [Full Text] [Related]
24. [Cardiovascular-protective effect of tadalafil in the treatment of erectile dysfunction]. Liu Y. Zhonghua Nan Ke Xue; 2013 Dec; 19(12):1147-51. PubMed ID: 24432631 [Abstract] [Full Text] [Related]
25. Tadalafil improved erectile function at twenty-four and thirty-six hours after dosing in men with erectile dysfunction: US trial. Young JM, Feldman RA, Auerbach SM, Kaufman JM, Garcia CS, Shen W, Murphy AM, Beasley CM, Hague JA, Ahuja S. J Androl; 2005 Dec; 26(3):310-8. PubMed ID: 15866997 [Abstract] [Full Text] [Related]
27. Effect on sexual function of a vacuum erection device post-prostatectomy. Engel JD. Can J Urol; 2011 Jun; 18(3):5721-5. PubMed ID: 21703048 [Abstract] [Full Text] [Related]
28. Efficacy and safety of tadalafil in men with erectile dysfunction following spinal cord injury. Giuliano F, Sanchez-Ramos A, Löchner-Ernst D, Del Popolo G, Cruz N, Leriche A, Lombardi G, Reichert S, Dahl P, Elion-Mboussa A, Casariego J. Arch Neurol; 2007 Nov; 64(11):1584-92. PubMed ID: 17846260 [Abstract] [Full Text] [Related]
29. Analysis of the therapeutic effect of tadalafil on male ED after transurethral resection of prostate. Yu H, Wu H, Rao D. Int J Impot Res; 2012 Nov; 24(4):147-9. PubMed ID: 22513502 [Abstract] [Full Text] [Related]
34. Time from dosing to sexual intercourse attempts in men taking tadalafil in clinical trials. Shabsigh R, Burnett AL, Eardley I, Sharlip ID, Ellsworth PI, Garcia CS, Natanegara F, Ahuja S. BJU Int; 2005 Oct; 96(6):857-63. PubMed ID: 16153217 [Abstract] [Full Text] [Related]
36. Tadalafil improves lean mass and endothelial function in nonobese men with mild ED/LUTS: in vivo and in vitro characterization. Aversa A, Fittipaldi S, Francomano D, Bimonte VM, Greco EA, Crescioli C, Di Luigi L, Lenzi A, Migliaccio S. Endocrine; 2017 Jun; 56(3):639-648. PubMed ID: 28133708 [Abstract] [Full Text] [Related]
37. The efficacy of tadalafil in improving sexual satisfaction and overall satisfaction in men with mild, moderate, and severe erectile dysfunction: a retrospective pooled analysis of data from randomized, placebo-controlled clinical trials. Rosen RC, Shabsigh R, Kuritzky L, Wang WC, Sides GD. Curr Med Res Opin; 2005 Nov; 21(11):1701-9. PubMed ID: 16307689 [Abstract] [Full Text] [Related]
39. Patterns of switching phosphodiesterase type 5 inhibitors in the treatment of erectile dysfunction: results from the Erectile Dysfunction Observational Study. Hatzichristou D, Haro JM, Martin-Morales A, von Keitz A, Riley A, Bertsch J, Belger M, Wolka AM, Beardsworth A, EDOS Group. Int J Clin Pract; 2007 Nov; 61(11):1850-62. PubMed ID: 17850306 [Abstract] [Full Text] [Related]